Myriad Genetics (MYGN) Tops Q3 EPS by 1c, Beats on Revenue; Offers FY25 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mail
Get Alerts MYGN Hot Sheet
Price: $6.35 -4.8%
Revenue Growth %: -7.0%
Financial Fact:
Earnings per basic share: -0.02
Today's EPS Names:
OPY, BNCC, ZVOI, More
Revenue Growth %: -7.0%
Financial Fact:
Earnings per basic share: -0.02
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Myriad Genetics (NASDAQ: MYGN) reported Q3 EPS of $0.00, $0.01 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $205.7 million versus the consensus estimate of $204.97 million.
GUIDANCE:
Myriad Genetics sees FY2025 EPS of ($0.02)-$0.02, versus the consensus of $0.01. Myriad Genetics sees FY2025 revenue of $818-828 million, versus the consensus of $822.4 million.
For earnings history and earnings-related data on Myriad Genetics (MYGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kosmos Energy (KOS) Misses Q3 EPS by 3c
- HSBC Upgrades Delhivery Ltd (DELHIVER:IN) to Buy
- Morgan Stanley Upgrades CaixaBank SA (CABK:SM) (CAIXY) to Overweight, Top Pick
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
